Through
5/7
mRNA Research
Five things to know about the promising COVID-19 vaccine news
Five things to know about the promising COVID-19 vaccine news
Drew Weissman of the Perelman School of Medicine, whose work is a key factor helping to enable two vaccines in late stages of testing, sheds light on the biology behind them and on his predictions about next steps in vaccine development and approval.
Penn nanoparticles are less toxic to T cells engineered for cancer immunotherapy
Penn nanoparticles are less toxic to T cells engineered for cancer immunotherapy
By using messenger RNA across the T cell’s membrane via a nanoparticle instead of a DNA-rewriting virus on extracted T cells, CAR T treatments could have fewer side effects.
How plants cope with stress
How plants cope with stress
With climate change comes drought, and with drought comes higher salt concentrations in the soil. Brian Gregory and graduate student Stephen Anderson have identified a mechanism by which plants respond to salt stress, a pathway that could be targeted to engineer more adaptable crops.
In the News
Deutsche Welle
A vaccine for pancreatic cancer?
Drew Weissman of the Perelman School of Medicine comments on the efficacy of a potential pancreatic cancer vaccine.
FULL STORY →
Scientific American
Pancreatic cancer vaccine shows promise in small initial trial
Drew Weissman of the Perelman School of Medicine is supportive of findings about a pancreatic cancer vaccine, though he says larger studies are needed to determine effectiveness.
FULL STORY →